April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Novel Nonenzymatic Modifications of Lens Crystallins by Vitamin C Target Arginine Residues
Author Affiliations & Notes
  • I. Nemet
    Pathology, Case Western Reserve Univeristy, Cleveland, Ohio
  • X. Fan
    Pathology, Case Western Reserve Univeristy, Cleveland, Ohio
  • V. M. Monnier
    Pathology, Case Western Reserve Univeristy, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  I. Nemet, None; X. Fan, None; V.M. Monnier, None.
  • Footnotes
    Support  EY07099, VSCR P30EY-11373, and JDRF fellowship to IN
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4618. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      I. Nemet, X. Fan, V. M. Monnier; Novel Nonenzymatic Modifications of Lens Crystallins by Vitamin C Target Arginine Residues. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4618.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Lens crystallins are prone to chemical modifications that affect chaperone function and favor toward aggregation and cataractogenesis. Vitamin C degradation products participate significantly in these chemical pathways in the lens. However, the products described so far can be formed from sugars other than Vitamin C and therefore do not reflect the specific role of Vitamin C in the modification. Here we characterized the structure of novel crystallin ascorbylation adducts and crosslinks with target amino acids and lens crystallins in vitro and from mice expressing the human vitamin C transporter 2 (hSCVT2) in the lens.

Methods: : Boc protected amino acids, lysine and arginine were incubated with dehydroascorbic acid (DHA) under metal free conditions. Major incubation products were isolated by RP-HPLC and identified by NMR and mass spectrometry. These products were measured by LC-MSMS in bovine lens crystallins incubated with ascorbic acid or DHA (5 and 10 mM) for 7 days or crystallins from hSCVT2-mouse.

Results: : From the Lys-Arg-DHA incubation two previously described crosslinks were isolated Lys-Arg-3-deoxyerythrosone (1) and Lys-Arg-erythrosone (2). In the arginine-DHA model systems three novel hydroimidazolone products derived from xylosone (3), erythrosone (4) and 3-deoxyerythrosone (5) were identified.In crystallins incubated in vitro with 5 mM ascorbic acid or DHA crosslink 1 reached the levels of 2.0 and 41.6 pmol/mg of protein, while crosslink 2 reached the levels of 66 and 664 pmol/mg of protein, respectively. Level of hydroimidazolone 3 was 10.9 pmol/mg of protein in crystallins incubated with 10 mM DHA. Surprisingly, only the hydroimidazolone 3 was identified in levels of 226 pmol/mg protein from 3 months old hSVCT2 mouse lens, but crosslinks 1 and 2 were not detected.

Conclusions: : Novel products of protein modifications by Vitamin C which target arginine in crystallins were characterized and identified in vitro and in vivo systems. They could destabilize arginine residues and contribute toward impaired chaperone function during aging.

Keywords: crystallins • protein modifications-post translational • aging 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.